Timing and causes of death in severe COVID-19 patients.
Timing and causes of death in severe COVID-19 patients.
复制标题
DOI:
10.1186/s13054-021-03639-w
复制
发表时间:
2021-06-30
期刊:
影响因子:
--
通讯作者:
Llitjos JF
中科院分区:
文献类型:
--
作者:
de Roquetaillade C;Bredin S;Lascarrou JB;Soumagne T;Cojocaru M;Chousterman BG;Leclerc M;Gouhier A;Piton G;Pène F;Stoclin A;Llitjos JF
Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged ≥ 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included in the analysis. The causes and timing of ICU deaths were reported based on medical records. From March 1, 2020, to April 28, 287 patients were admitted to the ICU for SARS-CoV-2 related acute respiratory failure. Among them, 93 patients died in the ICU (32%). COVID-19-related multiple organ dysfunction syndrome (MODS) was the leading cause of death (37%). Secondary infection-related MODS accounted for 26% of ICU deaths, with a majority of ventilator-associated pneumonia. Refractory hypoxemia/pulmonary fibrosis was responsible for death in 19% of the cases. Fatal ischemic events (venous or arterial) occurred in 13% of the cases. The median time from ICU admission to death was 15 days (25th–75th IQR, 7–27 days). COVID-19-related MODS had a median time from ICU admission to death of 14 days (25th–75th IQR: 7–19 days), while only one death had occurred during the first 3 days since ICU admission. In our multicenter observational study, COVID-19-related MODS and secondary infections were the two leading causes of death, among severe COVID-19 patients admitted to the ICU.
登录
查看更多内容
DOI:
10.1186/s13054-020-03449-6
发表时间:
2021-01-04
期刊:
Critical care (London, England)
影响因子:
--
作者:
Contou D;Fraissé M;Pajot O;Tirolien JA;Mentec H;Plantefève G
通讯作者:
Plantefève G
DOI:
10.1186/s13054-021-03492-x
发表时间:
2021-02-23
期刊:
Critical care (London, England)
影响因子:
--
作者:
Contou D;Cally R;Sarfati F;Desaint P;Fraissé M;Plantefève G
通讯作者:
Plantefève G
DOI:
10.1086/591708
发表时间:
2008-10-01
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Morens DM;Taubenberger JK;Fauci AS
通讯作者:
Fauci AS
DOI:
10.1016/j.cmi.2020.07.016
发表时间:
2020-12
期刊:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子:
--
作者:
Langford BJ;So M;Raybardhan S;Leung V;Westwood D;MacFadden DR;Soucy JR;Daneman N
通讯作者:
Daneman N
影响因子:
38.9
作者:
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
通讯作者:
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators